Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Stephanie Chen, Marc Miravitlles, Chin Kook Rhee, Ian D Pavord, Rupert Jones, Victoria Carter, Benjamin Emmanuel, Marianna Alacqua & David B Price. (2022) Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2187-2200.
Read now
Read now
Yihui Fu, Lirong Liu & Haihong Wu. (2022) Role of Genetic Polymorphisms in IL12Rβ2 in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1671-1683.
Read now
Read now
Natalia Celejewska-Wójcik, Aleksander Kania, Karolina Górka, Paweł Nastałek, Krzysztof Wójcik, Anna Gielicz, Lucyna Mastalerz, Marek Sanak & Krzysztof Sładek. (2021) Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1415-1424.
Read now
Read now
Mario Cazzola, Josuel Ora, Francesco Cavalli, Paola Rogliani & Maria Gabriella Matera. (2021) An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease. Biologics: Targets and Therapy 15, pages 363-374.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta, Rosa Annibale, Francesco Russo & Mario Cazzola. (2021) Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert Review of Clinical Pharmacology 14:8, pages 1015-1027.
Read now
Read now
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Read now
Michael J. Hughes, Elizabeth Sapey & Robert Stockley. (2019) Neutrophil phenotypes in chronic lung disease. Expert Review of Respiratory Medicine 13:10, pages 951-967.
Read now
Read now
Articles from other publishers (15)
Lluc Riera-Martínez, Laura Cànaves-Gómez, Amanda Iglesias, Aina Martin-Medina & Borja G. Cosío. (2023) The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy. International Journal of Molecular Sciences 24:10, pages 8702.
Crossref
Crossref
Min Jiang, Zhiwei Li, Fengbo Zhang, Zheng Li, Dan Xu, Jing Jing, Fengsen Li, Jing Wang & Jianbing Ding. (2023) Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Huaqi Guo, Hengyi Yu, Yan Feng, Wei Cheng, Yan Li & Yan Wang. (2022) The role of estrogen receptor β in fine particulate matter (PM2.5) organic extract-induced pulmonary inflammation in female and male mice. Environmental Science and Pollution Research 29:40, pages 60922-60932.
Crossref
Crossref
Domenico Maurizio Toraldo, Emanuele Rizzo & Luana Conte. (2022) Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index. Naunyn-Schmiedeberg's Archives of Pharmacology 395:7, pages 849-858.
Crossref
Crossref
Cheng-Sen Cai & Jun Wang. (2022) Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients. Canadian Respiratory Journal 2022, pages 1-6.
Crossref
Crossref
Bryan J. Mathis, Misa Kusumoto, Alexander Zaboronok & Yuji Hiramatsu. (2021) Packaging and Delivery of Asthma Therapeutics. Pharmaceutics 14:1, pages 92.
Crossref
Crossref
Tzu-Tao Chen, Sheng-Ming Wu, Kuan-Yuan Chen, Chien-Hua Tseng, Shu-Chuan Ho, Hsiao-Chi Chuang, Po-Hao Feng, Wen-Te Liu, Chia-Li Han, Erick Wan-Chun Huang, Yun-Kai Yeh & Kang-Yun Lee. (2021) Suppressor of variegation 3–9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Misa Kusumoto & Bryan J. Mathis. (2021) Biologic Treatments for Asthma and Chronic Obstructive Pulmonary Disorder. Allergies 1:2, pages 92-107.
Crossref
Crossref
Mathieu Fieldes, Chloé Bourguignon, Said Assou, Amel Nasri, Aurélie Fort, Isabelle Vachier, John De Vos, Engi Ahmed & Arnaud Bourdin. (2021) Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Research 7:2, pages 00437-2020.
Crossref
Crossref
Robert M. Burkes, Ralph J. Panos & Michael T. Borchers. (2021) How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs. Current Opinion in Pulmonary Medicine 27:2, pages 120-124.
Crossref
Crossref
Benjamin David, Mona Bafadhel, Leo Koenderman & Antony De Soyza. (2021) Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax 76:2, pages 188-195.
Crossref
Crossref
Molly Easter, Seth Bollenbecker, Jarrod W. Barnes & Stefanie Krick. (2020) Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences 21:18, pages 6924.
Crossref
Crossref
David J. Jackson, Stephanie Korn, Sameer K. Mathur, Peter Barker, Venkata G. Meka, Ubaldo J. Martin & James G. Zangrilli. (2020) Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab. Drug Safety 43:5, pages 409-425.
Crossref
Crossref
Yuanyang Tan, Yongkang Qiao, Zhuanggui Chen, Jing Liu, Yanrong Guo, Thai Tran, Kai Sen Tan, De-Yun Wang & Yan Yan. (2020) FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD). Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Tae-Yang Jung, A Yeong Lee, Jun-Ho Song, Min Young Lee, Je-Oh Lim, Se-Jin Lee, Je-Won Ko, Na-Rae Shin, Jong-Choon Kim, In-Sik Shin & Joong-Sun Kim. (2020) Scrophularia koraiensis Nakai Attenuates Allergic Airway Inflammation via Suppression of NF-κB and Enhancement of Nrf2/HO-1 Signaling. Antioxidants 9:2, pages 99.
Crossref
Crossref